State Street
IRON icon

State Street’s Disc Medicine IRON Stock Holding History

State Street’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$109M Buy
1,698,244
+510,253
+43% +$35.4M ﹤0.01% 1331
2025
Q4 		$94.3M Buy
1,187,991
+142,394
+14% +$12M ﹤0.01% 1397
2025
Q3 		$69.1M Buy
1,045,597
+115,829
+12% +$6.89M ﹤0.01% 1565
2025
Q2 		$49.2M Buy
929,768
+11,201
+1% +$526K ﹤0.01% 1689
2025
Q1 		$45.6M Buy
918,567
+149,832
+19% +$8.33M ﹤0.01% 1694
2024
Q4 		$48.7M Sell
768,735
-59,175
-7% -$3.42M ﹤0.01% 1731
2024
Q3 		$40.7M Buy
827,910
+235,115
+40% +$11M ﹤0.01% 1805
2024
Q2 		$26.7M Sell
592,795
-498,416
-46% -$16.9M ﹤0.01% 2016
2024
Q1 		$67.9M Buy
1,091,211
+532,016
+95% +$34.5M ﹤0.01% 1547
2023
Q4 		$32.3M Sell
559,195
-108,106
-16% -$5.54M ﹤0.01% 1932
2023
Q3 		$31.3M Buy
667,301
+527,898
+379% +$26.4M ﹤0.01% 1895
2023
Q2 		$6.19M Buy
139,403
+124,916
+862% +$4.43M ﹤0.01% 2897
2023
Q1 		$307K Buy
14,487
+4,298
+42% +$95.8K ﹤0.01% 3921
2022
Q4 		$203K Buy
10,189
+6,792
+200% +$338K ﹤0.01% 4092
2022
Q3 		$167K Hold
3,397
– – ﹤0.01% 4219
2022
Q2 		$172K Sell
3,397
-10,226
-75% -$452K ﹤0.01% 4275
2022
Q1 		$568K Sell
13,623
-118
-0.9% -$6.19K ﹤0.01% 3992
2021
Q4 		$1.2M Sell
13,741
-103
-0.7% -$10.1K ﹤0.01% 3772
2021
Q3 		$1.68M Buy
13,844
+3,573
+35% +$488K ﹤0.01% 3658
2021
Q2 		$1.99M Buy
10,271
+9,644
+1,538% +$3.17M ﹤0.01% 3549
2021
Q1 		$255K Buy
+627
New +$280K ﹤0.01% 3811

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return